Atossa Therapeutics, Inc. (ATOS) has 18 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Guse Kyle avec 557,900 actions. Parmi les autres détenteurs notables Rees Heather et Chen Ben R.
Au cours des 12 derniers mois, les initiés ont effectué 15 transactions sur ATOS l'action — 14 achats (d'une valeur de $3.24M) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
ATOS Participations des Initiés
Principal Actionnaire
Guse Kyle
557,900 actions
Achats (12 mois)
14
$3.24M valeur
Ventes (12 mois)
0
$0.00 valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Guse Kyle |
CFO, Gen Counsel and Secretary |
557,900 |
2023-03-06 |
|
| 2 |
Rees Heather |
Chief Financial Officer |
543,785 |
2025-05-16 |
|
| 3 |
Chen Ben R |
Sr. VP of Glob. Reg. Affairs |
300,000 |
2014-04-03 |
|
| 4 |
Youmans Scott |
Chief Operating Officer |
286,217 |
2015-09-03 |
|
| 5 |
Chen Shu-chih |
Director |
125,000 |
2025-05-16 |
|
| 6 |
Finn Jonathan |
Director |
125,000 |
2025-05-16 |
|
| 7 |
Remmel H. Lawrence |
Director |
125,000 |
2025-05-16 |
|
| 8 |
Steinhart Richard I |
Director |
125,000 |
2025-05-16 |
|
| 9 |
Cigler Tessa |
Director |
125,000 |
2025-05-16 |
|
| 10 |
Galli Stephen J |
Director |
125,000 |
2025-05-16 |
|
| 11 |
Cross Alexander D |
Director |
88,866 |
2013-06-27 |
|
| 12 |
Quay Steven C |
President & CEO |
88,038 |
2026-03-31 |
|
| 13 |
Daniel Mark James |
Chief Financial Officer |
63,000 |
2026-03-30 |
|
| 14 |
Sawyer John E |
See Remarks |
59,265 |
2015-03-18 |
|
| 15 |
Destro Christopher S. |
SVP, Sales and Marketing |
54,625 |
2015-03-18 |
|
| 16 |
Carbonaro Peter J. |
Sr. Vice President, Operations |
45,000 |
2014-05-08 |
|
| 17 |
Barnhart John |
Director |
44,882 |
2013-05-09 |
|
| 18 |
Weaver Gregory L |
Former EVP, CFO, & Director |
55 |
2023-11-17 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-27 |
Quay Steven C |
President & CEO |
Attribution de RSU |
65,000 |
- |
- |
| 2026-03-26 |
Daniel Mark James |
Chief Financial Officer |
Attribution de RSU |
63,000 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
Attribution de RSU |
331,674 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
Attribution de RSU |
325,203 |
- |
- |
| 2025-10-14 |
Daniel Mark James |
Chief Financial Officer |
Attribution de RSU |
578,000 |
$1.03 |
$595.34K |
| 2025-10-14 |
Daniel Mark James |
Officer |
Inconnu |
- |
- |
- |
| 2025-05-21 |
Quay Steven C |
President & CEO |
Achat Informatif |
11,239 |
$0.88 |
$9.89K |
| 2025-05-15 |
Cigler Tessa |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Rees Heather |
Chief Financial Officer |
Attribution de RSU |
543,785 |
$0.99 |
$538.35K |
| 2025-05-15 |
Finn Jonathan |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Chen Shu-chih |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Galli Stephen J |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Remmel H. Lawrence |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Steinhart Richard I |
Director |
Attribution de RSU |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Quay Steven C |
President & CEO |
Attribution de RSU |
1,366,062 |
$0.99 |
$1.35M |
Les autres consultent aussi
